Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses. - Wikidata - wikimedia - TriplyDB

Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses.

Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses.

http://www.wikidata.org/entity/Q42941808

about

Cellular targeting in autoimmunity Deletion of a CD2-like gene, 8-DR, from African swine fever virus affects viral infection in domestic swine.Association of p59(fyn) with the T lymphocyte costimulatory receptor CD2. Binding of the Fyn Src homology (SH) 3 domain is regulated by the Fyn SH2 domain.The CD58 (LFA-3) binding site is a localized and highly charged surface area on the AGFCC'C" face of the human CD2 adhesion domain.Personalized medicine in psoriasis: developing a genomic classifier to predict histological response to Alefacept.Biologics in dermatologic therapy - an update.Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris Selective targeting of human alloresponsive CD8+ effector memory T cells based on CD2 expression.The pathophysiological role of dendritic cell subsets in psoriasis.Signaling through the lymphotoxin beta receptor induces the death of some adenocarcinoma tumor lines Novel targeted therapies for eosinophil-associated diseases and allergy Selective targeting of T cell subsets: focus on alefacept - a remittive therapy for psoriasis.Peyer's patches are required for oral tolerance to proteins.Treatment targeted to cell surface epitopes.The role of T cells in psoriasis.Reduction of bleomycin induced lung fibrosis by transforming growth factor beta soluble receptor in hamsters.Psoriasis treatment: current and emerging directed therapies.BAFF binds to the tumor necrosis factor receptor-like molecule B cell maturation antigen and is important for maintaining the peripheral B cell population.Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis.Alefacept: a review of the literature and practical guidelines for management.Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients.The vertebral artery: a review of anatomical, histopathological and functional factors influencing blood flow to the hindbrain.T cell targeted immunotherapy for autoimmune disease.Interaction between human CD2 and CD58 involves the major beta sheet surface of each of their respective adhesion domains.T cell receptor- and beta 1 integrin-mediated signals synergize to induce tyrosine phosphorylation of focal adhesion kinase (pp125FAK) in human T cells Immune interventions to preserve β cell function in type 1 diabetes Therapeutic potential of selectin antagonists in psoriasis.Biologic agents in psoriasis.The safety and efficacy of alefacept in the treatment of chronic plaque psoriasis.Disrupted splenic architecture, but normal lymph node development in mice expressing a soluble lymphotoxin-beta receptor-IgG1 fusion protein.Novel targeted therapies for eosinophilic disorders Can We Repurpose FDA-Approved Alefacept to Diminish the HIV Reservoir?Emerging drugs for atopic dermatitis.Configuration of the interferon-alpha/beta receptor complex determines the context of the biological response.Chimeric fusion proteins used for therapy: indications, mechanisms, and safety.Targeting memory T cells in type 1 diabetes.Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid- and Calcineurin Inhibitor-Free Future?Restoring Regulatory T Cells in Type 1 Diabetes.Role of Memory T Cells in Allograft Rejection and Tolerance Pathophysiologic role of alpha 4 integrins in the lung.

P2860

Q26824580-D3A8984C-2886-40C8-9A47-5EB84113FEC5 Q27469555-970280F9-5C7D-46D9-88D4-4A62AB54E17C Q30176114-C9EF7EDA-1457-4596-8EE8-567EF7C6E064 Q30194655-0E153764-7E35-4218-8C33-C386B31755CC Q33530942-B8DE64A8-1075-44E2-8C0F-4D82DC4760F7 Q33607620-96C1BDE6-1513-4D08-AFDD-2801BC73BBC6 Q33757065-5DA023F7-992C-4572-A24F-D5AD2214D474 Q34149246-50B0EB66-8F12-4CB9-B51D-814EB8F47494 Q34180103-ACB934C6-20E5-4F22-958C-65059313F29D Q34381306-927D66C3-AD89-4BF7-B5D8-07D9249DF4A2 Q34444620-21236E30-496F-423D-A3AE-D890BDD7033F Q34602577-179EAD9E-9310-4173-AB8E-EECB9734BA2F Q34725322-538A6BEA-4B3B-424B-8AE6-829D4019EC2F Q35015866-B6A66F65-7AE0-4EFB-BDFE-23394AB350F4 Q35110104-2D40CB7E-461D-4225-9D19-90F7C65B29D9 Q35533319-BC127CB9-6F87-4ED8-8D16-F060F54CADD2 Q35579427-8AC040C4-99AA-4C5C-8CA2-48FBB684BCEF Q35834649-9ED9DD95-41C8-45D5-83A0-E30E87DBC172 Q35868862-552AB9B8-B7AC-42C8-860B-C95DF169E5CC Q35893152-28267585-03D8-4C59-ABD9-FD7DB1364899 Q36216535-CBF89F71-C545-4667-9C15-7EDCCB3834FB Q36356951-847763F6-3311-468F-B77A-DB627746A9F8 Q36359571-8CCFBD6C-3DC9-4799-8D48-7356915C0C41 Q36364046-56F0C3D8-4F44-4373-826E-FA13B387808E Q36365690-7549077A-28F3-45BE-A592-D646EE521E43 Q36520618-46BD8FFF-94C5-49F3-8A0C-8B9106B5418F Q36543080-49A44A09-C29C-44AB-893B-69F37180035E Q36620700-C6B5B729-4040-4043-8FAF-9290A7E5F8EB Q36661303-4F460FFA-3562-4851-9079-80F71CA58273 Q36688075-BAECDAE6-41E3-4786-9FDA-5DB6A9F92333 Q36763565-AB1D8142-C19C-4156-9176-B3AAE5FD8367 Q36827134-618A2F0F-43A8-4734-8861-95D8DD37926D Q37392901-4CCF5B21-5550-4AD6-B1F1-178729729B8E Q38291454-951E0EDA-8B41-41B9-80D8-9B73B37FF327 Q38400396-945289A9-5465-4A4A-852D-5B28298E8D32 Q38586890-2A360E4F-695E-4AC2-9D3D-2D20861305DC Q38804454-00FABE2F-4C6E-4D42-9D43-C47D96346109 Q38963375-35F4C6BF-F4C9-4A81-A92C-4A5012ED011F Q39178547-FEE3E96E-57BB-49E8-B682-E33E8348FEF4 Q40923050-4D91FA8C-D7D5-43AA-B369-26324DA1EC30

P2860

Specific interaction of lymphocyte function-associated antigen 3 with CD2 can inhibit T cell responses.

http://www.wikidata.org/entity/Q42941808

description

1993 nî lūn-bûn

@nan

1993年の論文

@ja

1993年論文

@yue

1993年論文

@zh-hant

1993年論文

@zh-hk

1993年論文

@zh-mo

1993年論文

@zh-tw

1993年论文

@wuu

1993年论文

@zh

1993年论文

@zh-cn

name

Specific interaction of lympho ...... can inhibit T cell responses.

@en

Specific interaction of lympho ...... can inhibit T cell responses.

@nl

type

label

Specific interaction of lympho ...... can inhibit T cell responses.

@en

Specific interaction of lympho ...... can inhibit T cell responses.

@nl

prefLabel

Specific interaction of lympho ...... can inhibit T cell responses.

@en

Specific interaction of lympho ...... can inhibit T cell responses.

@nl

P1433

Q42941808-7126C64F-774C-4E73-B957-A3806C34117A

P1476

Q42941808-0AB4C108-3C37-43B5-A03B-D49A96F3F37C

P2093

Q42941808-08DE887E-2DBE-4868-82F8-2B97E0C5ACBA

Q42941808-21E44D42-E16C-486D-B3EA-8875EA85AD7A

Q42941808-618D569A-5E2D-4E79-A641-9B2617335C02

Q42941808-720824F6-9E31-4729-9116-73E095732ACF

Q42941808-73BB05AD-ED7C-4406-BB8F-75C234DAC4B4

Q42941808-A1BEACD4-E39C-437C-AE8E-C51EE45C2A55

Q42941808-C3090360-0D6B-49F0-A922-C2F25D4B67D4

P2860

Q42941808-08294B98-DFE7-4E45-8AB0-866EDB3218B9

Q42941808-28CF25B1-8EBF-4443-A4F5-8DCCDB4CD6F0

Q42941808-2B2168BF-0247-4828-914B-FB86D8DF5026

Q42941808-3F112657-0EA9-4022-B3A4-9A90DD77090A

Q42941808-44D4D96E-0BA5-4697-85BE-2A2493C9EE09

Q42941808-4E4761F4-D534-4561-B78A-94A0102FA47F

Q42941808-64AAD8AB-7504-4533-907F-0791E81806F1

Q42941808-6A7BAD21-AA52-4C00-B2D3-9835877F2E82

Q42941808-6CB72076-D596-4C3A-80F0-37E7E0E5922C

Q42941808-7052284B-1F3C-4CEA-A482-7124771EBFAC

P304

Q42941808-67CB1FDC-5C8D-40B1-99CC-6C973C9FF64D

P31

Q42941808-EB16C01B-8DFD-49F2-8AF6-076E3E899756

P356

Q42941808-34866F1D-0851-4587-9ACE-F69835B83916

P407

Q42941808-66615A5C-8F4A-45CB-8652-EBE6E856C12C

P433

Q42941808-1C7C041A-F61C-41FD-BF03-E80555A74976

P478

Q42941808-D4E62C96-0223-4199-9895-CDE58A4EF3DA

P577

Q42941808-252F31B8-EFD9-4999-B276-BCAAFB56614F

P5875

Q42941808-3FD31362-4431-4622-A3CC-524E80308C78

P698

Q42941808-F3DD86F4-6240-4FF0-A21F-4BECADF7E34B

P932

Q42941808-DEC1C216-642A-42D5-A81E-EED60E4B0041

P356

P1433

Journal of Experimental Medicine

P1476

Specific interaction of lympho ...... can inhibit T cell responses.

@en

P2093

Bixler SA

http://www.w3.org/2001/XMLSchema#string

Hochman PS

http://www.w3.org/2001/XMLSchema#string

Meier W

http://www.w3.org/2001/XMLSchema#string

Miller GT

http://www.w3.org/2001/XMLSchema#string

Rosa MD

http://www.w3.org/2001/XMLSchema#string

Tizard R

http://www.w3.org/2001/XMLSchema#string

Wallner BP

http://www.w3.org/2001/XMLSchema#string

P2860

The MRC OX-45 antigen of rat leukocytes and endothelium is in a subset of the immunoglobulin superfamily with CD2, LFA-3 and carcinoembryonic antigens

Sequencing end-labeled DNA with base-specific chemical cleavages

Monoclonal antibody and ligand binding sites of the T cell erythrocyte receptor (CD2)

An LFA-3 cDNA encodes a phospholipid-linked membrane protein homologous to its receptor CD2

CD45 regulates signal transduction and lymphocyte activation by specific association with receptor molecules on T or B cells.

Interdependence of CD3-Ti and CD2 activation pathways in human T lymphocytes.

Primary structure of lymphocyte function-associated antigen 3 (LFA-3). The ligand of the T lymphocyte CD2 glycoprotein.

Role of lymphocyte adhesion receptors in transient interactions and cell locomotion.

Role of interaction of CD2 molecules with lymphocyte function-associated antigen 3 in T-cell recognition of nominal antigen.

Both T cell receptor (TcR)-CD3 complex and CD2 increase the tyrosine kinase activity of p56lck. CD2 can mediate TcR-CD3-independent and CD45-dependent activation of p56lck.

P304

211-222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1084/JEM.178.1.211

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

178

http://www.w3.org/2001/XMLSchema#string

P577

1993-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

277441444

http://www.w3.org/2001/XMLSchema#string

P698

7686212

http://www.w3.org/2001/XMLSchema#string

P932

2191085

http://www.w3.org/2001/XMLSchema#string